Endovascular therapy for vasospasm after aneurysmatic subarachnoid hemorrhage

References

• Connolly ES, Jr., Rabinstein AA, Carhuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke 2012;43:1711–37.
   PubMed Web of Science ®Google Scholar
• Macdonald RL. Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neur 2014;10:44–58.
   PubMed Web of Science ®Google Scholar
• Kerz T, Boor S, Beyer C, et al. Effect of intraarterial papaverine or nimodipine on vessel diameter in patients with cerebral vasospasm after subarachnoid hemorrhage. Br J Neurosurg 2012;26:517–24.
   PubMed Web of Science ®Google Scholar
• Kirkpatrick PJ, Turner CL, Smith C, et al. Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial. Lancet Neurol 2014;13:666–75.
   PubMed Web of Science ®Google Scholar
• Jun P, Ko NU, English JD, et al. Endovascular treatment of medically refractory cerebral vasospasm following aneurysmal subarachnoid hemorrhage. AJNR Am J Neuroradiol 2010;31:1911–6.
   PubMed Web of Science ®Google Scholar
• Terry A, Zipfel G, Milner E, et al. Safety and technical efficacy of over-the-wire balloons for the treatment of subarachnoid hemorrhage-induced cerebral vasospasm. Neurosurg Focus 2006;21:E14.
   Google Scholar
• Abruzzo T, Moran C, Blackham KA, et al. Invasive interventional management of post-hemorrhagic cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurointerv Surg 2012;4:169–77.
   PubMed Web of Science ®Google Scholar
• Zwienenberg-Lee M, Hartman J, Rudisill N, Muizelaar JP. Endovascular management of cerebral vasospasm. Neurosurgery 2006;59:S139–S47.
   Google Scholar
• Oskouian RJ, Jr., Martin NA, Lee JH, et al. Multimodal quantitation of the effects of endovascular therapy for vasospasm on cerebral blood flow, transcranial doppler ultrasonographic velocities, and cerebral artery diameters. Neurosurgery 2002;51:30–41.
   PubMed Web of Science ®Google Scholar
• Aburto-Murrieta Y, Marquez-Romero JM, Bonifacio-Delgadillo D, et al. Endovascular treatment: balloon angioplasty versus nimodipine intra-arterial for medically refractory cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Vasc Endovascular Surg 2012;46:460–5.
   PubMed Web of Science ®Google Scholar
• Chalouhi N, Tjoumakaris S, Thakkar V, et al. Endovascular management of cerebral vasospasm following aneurysm rupture: outcomes and predictors in 116 patients. Clin Neurol Neurosurg 2014;118:26–31.
   PubMed Web of Science ®Google Scholar
• Mortimer AM, Steinfort B, Faulder K, et al. The detrimental clinical impact of severe angiographic vasospasm may be diminished by maximal medical therapy and intensive endovascular treatment. J Neurointerv Surg 2015;7:881–7.
   PubMed Web of Science ®Google Scholar
• Chen PR. The intra-arterial vasospasm trial (IVT) 2014. Available from: https://clinicaltrials.gov/ct2/show/NCT01996436 [last accessed 4 Feb 2015].
   Google Scholar
• Biondi A, Ricciardi GK, Puybasset L, et al. Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results. AJNR Am J Neuroradiol 2004;25:1067–76.
   PubMed Web of Science ®Google Scholar
• Hui C, Lau KP. Efficacy of intra-arterial nimodipine in the treatment of cerebral vasospasm complicating subarachnoid haemorrhage. Clin Radiol 2005;60:1030–6.
   PubMed Web of Science ®Google Scholar
• Kim JH, Park IS, Park KB, et al. Intraarterial nimodipine infusion to treat symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Korean Neurosurg Soc 2009;46:239–44.
   PubMed Web of Science ®Google Scholar
• John S, Spiotta AM, Turner RM, et al. Initial experience with the coaxial dual-lumen Scepter C balloon catheter for endovascular management of cerebral vasospasm from subarachnoid hemorrhage. J Neurointerv Surg 2014;6:125–8.
   PubMed Web of Science ®Google Scholar
• Ducruet AF, Albuquerque FC, Crowley RW, et al. Balloon-pump counterpulsation for management of severe cardiac dysfunction after aneurysmal subarachnoid hemorrhage. World Neurosurg 2013;80:e347–52.
   Google Scholar
• Pluta RM. Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH. Acta Neurochir Suppl 2008;104:139–47.
   PubMedGoogle Scholar
• Sabri M, Ai J, Knight B, et al. Uncoupling of endothelial nitric oxide synthase after experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab 2011;31:190–9.
   PubMed Web of Science ®Google Scholar
• Macdonald RL, Higashida RT, Keller E, et al. Preventing vasospasm improves outcome after aneurysmal subarachnoid hemorrhage: rationale and design of CONSCIOUS-2 and CONSCIOUS-3 trials. Neurocritical Care 2010;13:416–24.
   PubMed Web of Science ®Google Scholar
• Laskowitz DT, Kolls BJ. Neuroprotection in subarachnoid hemorrhage. Stroke 2010;41:S79–84.
   PubMed Web of Science ®Google Scholar